XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Interim Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 83,574 $ 95,966
Trade accounts receivable, less allowances 648,002 709,321
Inventories 394,959 441,694
Other current assets and prepaid expenses 119,971 128,108
Total current assets 1,246,506 1,375,089
Property, plant and equipment, net 780,723 778,600
Goodwill 665,100 660,170
Other intangible assets, net 294,594 306,054
Deferred tax assets, net 27,836 27,080
Other non-current assets 355,636 345,402
Total assets 3,370,395 3,492,395
Current liabilities:    
Trade accounts payable 170,230 252,538
Accrued and other liabilities 177,590 205,253
Accrued compensation and related items 139,614 200,031
Deferred Revenue 204,549 192,759
Taxes payable 208,655 191,096
Short-term borrowings and current maturities of long-term debt 107,365 106,054
Total current liabilities 1,008,003 1,147,731
Long-term debt 2,045,462 1,908,480
Deferred tax liabilities, net 116,009 111,360
Other non-current liabilities 290,626 300,031
Total liabilities 3,460,100 3,467,602
Commitments and contingencies (Note 15)  
Shareholders' equity:    
Preferred stock, $0.01 par value per share; authorized 10,000,000 shares 0 0
Common stock, $0.01 par value per share; authorized 125,000,000 shares; issued 44,786,011 and 44,786,011 shares; outstanding 23,794,563 and 24,125,317 shares at September 30, 2020 and December 31, 2019, respectively 448 448
Additional paid-in capital 861,404 850,368
Treasury stock at cost (20,991,448 shares at September 30, 2020 and 20,660,694 shares at December 31, 2019) (7,811,028) (7,325,656)
Retained earnings 7,126,687 6,726,866
Accumulated other comprehensive loss (267,216) (227,233)
Total shareholders' equity (89,705) 24,793
Total liabilities and shareholders' equity $ 3,370,395 $ 3,492,395